25.64
Overview
News
Price History
Option Chain
Why PHG Down?
Discussions
Forecast
Stock Split
Dividend History
Koninklijke Philips N V Adr stock is traded at $25.64, with a volume of 1.00M.
It is up +0.20% in the last 24 hours and up +16.12% over the past month.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.
See More
Previous Close:
$25.59
Open:
$25.58
24h Volume:
1.00M
Relative Volume:
1.08
Market Cap:
$21.65B
Revenue:
$19.49B
Net Income/Loss:
$-757.52M
P/E Ratio:
-32.52
EPS:
-0.7885
Net Cash Flow:
-
1W Performance:
+1.50%
1M Performance:
+16.12%
6M Performance:
-5.32%
1Y Performance:
-1.13%
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Name
Koninklijke Philips N V Adr
Sector
Industry
Phone
-
Address
-
Compare PHG with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PHG
Koninklijke Philips N V Adr
|
25.64 | 21.65B | 19.49B | -757.52M | 0 | -0.7885 |
![]()
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-25-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Feb-20-25 | Upgrade | UBS | Neutral → Buy |
Oct-29-24 | Upgrade | Jefferies | Underperform → Hold |
May-13-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
May-07-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
Apr-30-24 | Upgrade | JP Morgan | Underweight → Neutral |
Apr-30-24 | Upgrade | UBS | Sell → Neutral |
Feb-07-24 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
Jul-12-23 | Initiated | Goldman | Buy |
Jan-17-23 | Downgrade | UBS | Neutral → Sell |
Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
Oct-14-22 | Downgrade | Deutsche Bank | Hold → Sell |
Sep-12-22 | Upgrade | Societe Generale | Hold → Buy |
Sep-06-22 | Upgrade | UBS | Sell → Neutral |
Jul-25-22 | Downgrade | Societe Generale | Buy → Hold |
Jun-16-22 | Downgrade | UBS | Neutral → Sell |
Jan-20-22 | Downgrade | Jefferies | Buy → Hold |
Jan-14-22 | Upgrade | HSBC Securities | Hold → Buy |
Jan-12-22 | Downgrade | Citigroup | Buy → Neutral |
Sep-08-21 | Initiated | Jefferies | Buy |
Jul-08-21 | Downgrade | Deutsche Bank | Buy → Hold |
Jun-21-21 | Downgrade | HSBC Securities | Buy → Hold |
Mar-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
Jul-28-20 | Initiated | Societe Generale | Buy |
Jul-30-19 | Initiated | Citigroup | Buy |
Feb-12-18 | Upgrade | Berenberg | Hold → Buy |
Nov-09-17 | Downgrade | JP Morgan | Overweight → Neutral |
Oct-16-17 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
Jun-21-17 | Downgrade | Natixis Bleichroeder | Buy → Neutral |
Apr-25-17 | Downgrade | Societe Generale | Buy → Hold |
Dec-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-23-16 | Initiated | Citigroup | Buy |
May-11-16 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
Mar-01-16 | Upgrade | HSBC Securities | Reduce → Hold |
Feb-16-16 | Downgrade | Jefferies | Hold → Underperform |
Nov-27-15 | Initiated | ING Group | Hold |
Sep-08-15 | Initiated | Credit Suisse | Outperform |
Aug-27-15 | Upgrade | Nomura | Neutral → Buy |
Jul-28-15 | Upgrade | Societe Generale | Hold → Buy |
Jan-25-11 | Downgrade | HSBC Securities | Overweight → Neutral |
Dec-07-09 | Upgrade | Deutsche Bank | Hold → Buy |
Oct-16-09 | Upgrade | HSBC Securities | Neutral → Overweight |
May-08-09 | Downgrade | UBS | Buy → Neutral |
View All
Koninklijke Philips N V Adr Stock (PHG) Latest News
Here's Why GE HealthCare Stock Sank in April - The Motley Fool
CBRE Group Inc (CBRE) Stock: A Closer Look at the Market Potential - News Heater
Taiwan Air Treatment Systems Industry Report: From AIoT to Wearables - GlobeNewswire Inc.
Selling Your Koninklijke Philips N.V. ADR (PHG) Stock? Here’s What You Need To Know - Stocks Register
Data-Based Insights About Koninklijke Philips N.V. ADR (PHG) - Stocks Register
Koninklijke Philips N.V. ADR (PHG) Shares Up Despite Recent Market Volatility - The News Heater
P3 Health Partners Inc (PIII) Stock: Evaluating the Annual Growth - The News Heater
Nabors Industries Ltd (NBR) Stock: A SWOT Analysis - The News Heater
Sun Country Airlines Holdings Inc (SNCY) Stock: A Value Analysis - The News Heater
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
Weekly Upgrades and Downgrades - InvestorPlace
Europe Cancer Diagnostics Market Size & Outlook, 2024-2030 - Grand View Research
Picture Archiving and Communication System Patent Landscape Report, 2024-2032 - GlobeNewswire Inc.
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Validea Kenneth Fisher Strategy Daily Upgrade Report10/29/2024 - Nasdaq
Philips has another Class I level ventilator recall - Mass Device
PHG vs. ESLOY: Which Stock Is the Better Value Option? - Yahoo Finance
China Operating Room Equipment Market Size & Outlook, 2030 - Grand View Research
New 4-Star Stocks - Morningstar
Philips to repurchase shares for up to $137.4M - Mass Device
Philips stock rises on Street-beating Q2 - Mass Device
Philips inks new multi-year patient monitoring collab - Mass Device
Philips wins FDA clearance for next-gen digital pathology system - Mass Device
GE HealthCare: Initiating Coverage With Wide Moat, Shares Look Attractive - Morningstar
Philips unveils new AI-powered cardiovascular ultrasound - Mass Device
Philips prices $758.6M offering, expands access to intracardiac echocardiography - Mass Device
Philips has positive AI-powered cardiac monitoring data - Mass Device
Philips announces exchange ratio for 2023 dividend - Philips
Philips Stock Books Record Gain After U.S. Ventilator Settlement - WSJ
Philips creates 'clear path forward' with FDA over Respironics probe - Sharecast.com
With 48% ownership in Koninklijke Philips N.V. (AMS:PHIA), institutional investors have a lot riding on the business - Yahoo Finance
Philips taps Stryker controller as next CFO - Mass Device
Philips unveils radiation-free imaging tech that uses light instead of X-ray - Mass Device
Philips unveils next-gen ultrasound systems - Mass Device
PHG Stock Quote Price and Forecast - CNN
Philips launches Visual Patient Avatar monitoring solution - Mass Device
Philips launches utrasound tech to boost cancer diagnostics - Mass Device
Philips says extended ECG Holter monitoring can improve diagnostic results - Mass Device
Markets Brief: Is the Bond Market’s Recession Indicator Broken? - Morningstar
Agnellis’ Exor Buys 15% Stake in Philips for Around $2.8 Billion - Bloomberg
Koninklijke Philips N V Adr Stock (PHG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):